March 18, 2020 / 1:11 PM / 20 days ago

BRIEF-Merck Announces Updates For Intr@Pid Lung 037 Clinical Study

March 18 (Reuters) - MERCK KGAA:

* STATEMENT ON UPCOMING CLINICALTRIALS.GOV UPDATES FOR THE INTR@PID LUNG 037 CLINICAL STUDY

* AN ADAPTIVE TRIAL DESIGN BASED ON PRE-SPECIFIED RULES TO DETERMINE WHETHER TO EXPAND TO PHASE III OR STAY AS PHASE II

* A CHANGE TO STUDY ENDPOINTS FROM ORR/PFS TO PFS/OS, THUS CONFIRMING THE REGISTRATIONAL INTENT AND INCORPORATING THE GUIDANCE FROM HEALTH AUTHORITIES Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below